# Ziprecruiter, Inc.: financial statements, quarterly

ZIP · NYSE · CIK 1617553 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/zip.md) · [Financials](/companies/zip/financials.md) · [Filings](/companies/zip/filings.md) · [Insiders](/companies/zip/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/zip/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [156](/filings/0001617553-24-000056.md) | [136 d](/filings/0001617553-26-000016.md) | [122](/filings/0001617553-25-000049.md) | [124](/filings/0001617553-25-000088.md) | [117](/filings/0001617553-25-000106.md) | [111 d](/filings/0001617553-26-000016.md) | [110](/filings/0001617553-26-000031.md) | [112](/filings/0001617553-26-000046.md) | [115](/filings/0001617553-25-000106.md) | [112 d](/filings/0001617553-26-000016.md) | [108](/filings/0001617553-26-000031.md) | [118](/filings/0001617553-26-000046.md) |
| Cost of revenue | $m | [14.5](/filings/0001617553-24-000056.md) | [13.5 d](/filings/0001617553-26-000016.md) | [13.3](/filings/0001617553-25-000049.md) | [12.9](/filings/0001617553-25-000088.md) | [12.4](/filings/0001617553-25-000106.md) | [11.5 d](/filings/0001617553-26-000016.md) | [11.7](/filings/0001617553-26-000031.md) | [12.0](/filings/0001617553-26-000046.md) | [12.5](/filings/0001617553-25-000106.md) | [12.1 d](/filings/0001617553-26-000016.md) | [12.0](/filings/0001617553-26-000031.md) | [12.6](/filings/0001617553-26-000046.md) |
| Gross profit | $m | [141](/filings/0001617553-24-000056.md) | [122 d](/filings/0001617553-26-000016.md) | [109](/filings/0001617553-25-000049.md) | [111](/filings/0001617553-25-000088.md) | [105](/filings/0001617553-25-000106.md) | [99.5 d](/filings/0001617553-26-000016.md) | [98.4](/filings/0001617553-26-000031.md) | [100](/filings/0001617553-26-000046.md) | [102](/filings/0001617553-25-000106.md) | [99.5 d](/filings/0001617553-26-000016.md) | [95.6](/filings/0001617553-26-000031.md) | [105](/filings/0001617553-26-000046.md) |
| Research and development | $m | [32.1](/filings/0001617553-24-000056.md) | [32.8 d](/filings/0001617553-26-000016.md) | [36.1](/filings/0001617553-25-000049.md) | [33.3](/filings/0001617553-25-000088.md) | [33.7](/filings/0001617553-25-000106.md) | [31.7 d](/filings/0001617553-26-000016.md) | [33.3](/filings/0001617553-26-000031.md) | [32.1](/filings/0001617553-26-000046.md) | [30.9](/filings/0001617553-25-000106.md) | [28.4 d](/filings/0001617553-26-000016.md) | [26.1](/filings/0001617553-26-000031.md) | [26.4](/filings/0001617553-26-000046.md) |
| Operating income | $m | [32.7](/filings/0001617553-24-000056.md) | [13.3 d](/filings/0001617553-26-000016.md) | [(0.9)](/filings/0001617553-25-000049.md) | [9.4](/filings/0001617553-25-000088.md) | [(3.2)](/filings/0001617553-25-000106.md) | [(4.0) d](/filings/0001617553-26-000016.md) | [(11.7)](/filings/0001617553-26-000031.md) | [(6.7)](/filings/0001617553-26-000046.md) | [(5.0)](/filings/0001617553-25-000106.md) | [4.0 d](/filings/0001617553-26-000016.md) | [(1.5)](/filings/0001617553-26-000031.md) | [4.1](/filings/0001617553-26-000046.md) |
| Interest expense | $m | [7.4](/filings/0001617553-23-000042.md) | [7.4 d](/filings/0001617553-24-000011.md) | [7.4](/filings/0001617553-24-000032.md) | [7.4](/filings/0001617553-25-000088.md) | [7.5](/filings/0001617553-25-000106.md) | [7.4 d](/filings/0001617553-26-000016.md) | [7.4](/filings/0001617553-26-000031.md) | [7.4](/filings/0001617553-26-000046.md) | [7.4](/filings/0001617553-25-000106.md) | [7.4 d](/filings/0001617553-26-000016.md) | [7.4](/filings/0001617553-26-000031.md) | [6.7](/filings/0001617553-26-000046.md) |
| Income tax | $m | [5.9](/filings/0001617553-24-000056.md) | [6.1 d](/filings/0001617553-26-000016.md) | [3.1](/filings/0001617553-25-000049.md) | [0.6](/filings/0001617553-25-000088.md) | [(1.8)](/filings/0001617553-25-000106.md) | [4.4 d](/filings/0001617553-26-000016.md) | [(0.9)](/filings/0001617553-26-000031.md) | [0.4](/filings/0001617553-26-000046.md) | [1.5](/filings/0001617553-25-000106.md) | [1.3 d](/filings/0001617553-26-000016.md) | [(0.8)](/filings/0001617553-26-000031.md) | [16.4](/filings/0001617553-26-000046.md) |
| Net income | $m | [24.1](/filings/0001617553-24-000056.md) | [5.6 d](/filings/0001617553-26-000016.md) | [(6.5)](/filings/0001617553-25-000106.md) | [7.0](/filings/0001617553-25-000106.md) | [(2.6)](/filings/0001617553-25-000106.md) | [(10.8) d](/filings/0001617553-26-000016.md) | [(12.8)](/filings/0001617553-26-000046.md) | [(9.5)](/filings/0001617553-26-000046.md) | [(9.8)](/filings/0001617553-25-000106.md) | [(0.8) d](/filings/0001617553-26-000016.md) | [(4.7)](/filings/0001617553-26-000046.md) | [43.4](/filings/0001617553-26-000046.md) |
| Diluted EPS | $ per share | [0.23](/filings/0001617553-24-000056.md) | not reported | [(0.07)](/filings/0001617553-25-000049.md) | [0.07](/filings/0001617553-25-000088.md) | [(0.03)](/filings/0001617553-25-000106.md) | not reported | [(0.13)](/filings/0001617553-26-000031.md) | [(0.10)](/filings/0001617553-26-000046.md) | [(0.11)](/filings/0001617553-25-000106.md) | not reported | [(0.06)](/filings/0001617553-26-000031.md) | [0.53](/filings/0001617553-26-000046.md) |
| Basic EPS | $ per share | [0.24](/filings/0001617553-24-000056.md) | not reported | [(0.07)](/filings/0001617553-25-000049.md) | [0.07](/filings/0001617553-25-000088.md) | [(0.03)](/filings/0001617553-25-000106.md) | not reported | [(0.13)](/filings/0001617553-26-000031.md) | [(0.10)](/filings/0001617553-26-000046.md) | [(0.11)](/filings/0001617553-25-000106.md) | not reported | [(0.06)](/filings/0001617553-26-000031.md) | [0.53](/filings/0001617553-26-000046.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [243](/filings/0001617553-23-000042.md) | [283](/filings/0001617553-25-000011.md) | [283](/filings/0001617553-24-000032.md) | [272](/filings/0001617553-24-000046.md) | [226](/filings/0001617553-24-000056.md) | [218](/filings/0001617553-26-000016.md) | [221](/filings/0001617553-25-000049.md) | [203](/filings/0001617553-26-000046.md) | [212](/filings/0001617553-25-000106.md) | [188](/filings/0001617553-26-000046.md) | [251](/filings/0001617553-26-000031.md) | [130](/filings/0001617553-26-000046.md) |
| Current assets | $m | [546](/filings/0001617553-23-000042.md) | [562](/filings/0001617553-25-000011.md) | [552](/filings/0001617553-24-000032.md) | [569](/filings/0001617553-24-000046.md) | [544](/filings/0001617553-24-000056.md) | [544](/filings/0001617553-26-000016.md) | [507](/filings/0001617553-25-000049.md) | [460](/filings/0001617553-25-000088.md) | [450](/filings/0001617553-25-000106.md) | [449](/filings/0001617553-26-000046.md) | [431](/filings/0001617553-26-000031.md) | [216](/filings/0001617553-26-000046.md) |
| Total assets | $m | [643](/filings/0001617553-23-000042.md) | [660](/filings/0001617553-25-000011.md) | [662](/filings/0001617553-24-000032.md) | [665](/filings/0001617553-24-000046.md) | [652](/filings/0001617553-24-000056.md) | [664](/filings/0001617553-26-000016.md) | [629](/filings/0001617553-25-000049.md) | [592](/filings/0001617553-25-000088.md) | [574](/filings/0001617553-25-000106.md) | [570](/filings/0001617553-26-000046.md) | [551](/filings/0001617553-26-000031.md) | [321](/filings/0001617553-26-000046.md) |
| Current liabilities | $m | [90.8](/filings/0001617553-23-000042.md) | [84.9](/filings/0001617553-25-000011.md) | [83.1](/filings/0001617553-24-000032.md) | [75.8](/filings/0001617553-24-000046.md) | [73.5](/filings/0001617553-24-000056.md) | [81.6](/filings/0001617553-26-000016.md) | [72.3](/filings/0001617553-25-000049.md) | [83.7](/filings/0001617553-25-000088.md) | [75.3](/filings/0001617553-25-000106.md) | [70.9](/filings/0001617553-26-000046.md) | [59.3](/filings/0001617553-26-000031.md) | [71.0](/filings/0001617553-26-000046.md) |
| Total liabilities | $m | [655](/filings/0001617553-23-000042.md) | [651](/filings/0001617553-25-000011.md) | [650](/filings/0001617553-24-000032.md) | [641](/filings/0001617553-24-000046.md) | [638](/filings/0001617553-24-000056.md) | [651](/filings/0001617553-26-000016.md) | [641](/filings/0001617553-25-000049.md) | [658](/filings/0001617553-25-000088.md) | [650](/filings/0001617553-25-000106.md) | [647](/filings/0001617553-26-000046.md) | [635](/filings/0001617553-26-000031.md) | [355](/filings/0001617553-26-000046.md) |
| Long-term debt | $m | [542](/filings/0001617553-23-000042.md) | [543](/filings/0001617553-25-000011.md) | [543](/filings/0001617553-24-000032.md) | [543](/filings/0001617553-24-000046.md) | [543](/filings/0001617553-24-000056.md) | [544](/filings/0001617553-26-000016.md) | [544](/filings/0001617553-25-000049.md) | [544](/filings/0001617553-25-000088.md) | [544](/filings/0001617553-25-000106.md) | [545](/filings/0001617553-26-000046.md) | [545](/filings/0001617553-26-000031.md) | [253](/filings/0001617553-26-000046.md) |
| Shareholders' equity | $m | [(11.9)](/filings/0001617553-24-000056.md) | [8.4](/filings/0001617553-26-000016.md) | [12.7](/filings/0001617553-25-000106.md) | [24.4](/filings/0001617553-25-000106.md) | [13.6](/filings/0001617553-25-000106.md) | [13.4](/filings/0001617553-26-000046.md) | [(11.3)](/filings/0001617553-26-000046.md) | [(65.9)](/filings/0001617553-26-000046.md) | [(76.1)](/filings/0001617553-25-000106.md) | [(77.2)](/filings/0001617553-26-000046.md) | [(83.8)](/filings/0001617553-26-000046.md) | [(33.8)](/filings/0001617553-26-000046.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [29.3 d](/filings/0001617553-24-000056.md) | [34.4 d](/filings/0001617553-26-000016.md) | [2.0](/filings/0001617553-25-000049.md) | [21.9 d](/filings/0001617553-25-000088.md) | [9.3 d](/filings/0001617553-25-000106.md) | [12.5 d](/filings/0001617553-26-000016.md) | [(9.9)](/filings/0001617553-26-000031.md) | [10.5 d](/filings/0001617553-26-000046.md) | [2.6 d](/filings/0001617553-25-000106.md) | [7.7 d](/filings/0001617553-26-000016.md) | [(3.5)](/filings/0001617553-26-000031.md) | [15.4 d](/filings/0001617553-26-000046.md) |
| Capital expenditure | $m | [0.4 d](/filings/0001617553-24-000056.md) | [0.1 d](/filings/0001617553-26-000016.md) | [0.1](/filings/0001617553-25-000049.md) | [0.2 d](/filings/0001617553-25-000088.md) | [0.2 d](/filings/0001617553-25-000106.md) | [0.4 d](/filings/0001617553-26-000016.md) | [0.3](/filings/0001617553-26-000031.md) | [0.3 d](/filings/0001617553-26-000046.md) | [0.4 d](/filings/0001617553-25-000106.md) | [0.1 d](/filings/0001617553-26-000016.md) | [0.1](/filings/0001617553-26-000031.md) | [0.2 d](/filings/0001617553-26-000046.md) |
| Share repurchases | $m | [28.3 d](/filings/0001617553-24-000056.md) | [8.4 d](/filings/0001617553-26-000016.md) | [6.4](/filings/0001617553-25-000049.md) | [8.6 d](/filings/0001617553-25-000088.md) | [22.6 d](/filings/0001617553-25-000106.md) | [2.7 d](/filings/0001617553-26-000016.md) | [27.5](/filings/0001617553-26-000031.md) | [56.6 d](/filings/0001617553-26-000046.md) | [10.0 d](/filings/0001617553-25-000106.md) | [8.0 d](/filings/0001617553-26-000016.md) | [9.5](/filings/0001617553-26-000031.md) | [0.0 d](/filings/0001617553-26-000046.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [120](/filings/0001617553-23-000042.md) | [110](/filings/0001617553-24-000032.md) | [105](/filings/0001617553-24-000046.md) | [105](/filings/0001617553-24-000056.md) | [99.0](/filings/0001617553-25-000049.md) | [103](/filings/0001617553-25-000088.md) | [98.5](/filings/0001617553-25-000106.md) | [98.1](/filings/0001617553-26-000031.md) | [90.6](/filings/0001617553-26-000046.md) | [86.3](/filings/0001617553-25-000106.md) | [83.7](/filings/0001617553-26-000031.md) | [82.7](/filings/0001617553-26-000046.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:44 ET. No prices; not investment advice.